Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × Leukapheresis × Clear all

NCT01326273 2015-06-08

Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Hematologic Neoplasms